Through continuous technological innovation and R&D breakthroughs, Yingrun Biotech has built a mature synthetic biology technology platform, forming a R&D and production system including new gene discovery technology, protein design and modification, gene efficient editing technology, cell chassis development and optimization, high-throughput screening, fermentation process optimization and amplification technology, etc., to achieve the transformation from basic research to practical application.

At the level of protein rational transformation design, breakthroughs have been made in complex protein crystal cultivation and co-crystallization technology, enzyme structure-function association design technology, and peptide molecular design technology, and cutting-edge technologies such as allosteric effect enzyme desensitization modification, stability modification, and activity modification have been used to help the in-depth development of highly effective and highly active raw materials.

Yingrun Biotech's efficacy evaluation system integrates cutting-edge theories of life science, chemistry, physics and clinical medicine, and combines advanced experimental equipment and data analysis methods to conduct multi-dimensional analysis of efficacy raw materials from micro to macro. Through cell experiments, tissue sections, skin models and human observation, on the basis of qualitative and quantitative testing, the internal mechanism and effect presentation of the efficacy of raw materials are further explored.
 

The company has a complete analysis and quality control platform, using instruments and equipment such as high performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) to test and identify products to ensure product purity and stability and guarantee product quality.

While focusing on the artificial rational design and functional optimization of efficacy products, we adopt cutting-edge scientific research results to improve the transdermal absorption efficiency of products and the bioavailability of active molecules.

We provide personalized efficacy solutions for customized active raw materials. The R&D platform has established a comprehensive human collagen peptide database, transdermal peptide database, etc., and has developed thousands of molecular enzyme products, as well as functional proteins, active peptides, small molecule active substances and other efficacy raw materials.